Background/Aims: Dysregulation of ubiquitin-associated protein 2-like (UBAP2L) has been reported in tumors, but its role in hepatocellular carcinoma (HCC) progression is unclear. Methods: The expression levels of UBAP2L in HCC tissues and HCC cell lines were detected by western blot and quantitative real-time (qRT) PCR. The effects of UBAP2L expression on HCC cell biological traits, including migration and invasion, were investigated by wound healing assay and matrigel transwell assay. Simultaneously, the expression of epithelial-mesenchymal transition (EMT) markers including E-cadherin, CK-18, N-cadherin, Vimentin, Claudin7 and the promoter activity of E-cadherin were detected by western blot and qRT-PCR. Subsequently, role of SNAIL1 in UBAP2L-mediated EMT and the mechanism underlying UBAP2L-mediated SNAIL1 expression were further investigated. Results: UBAP2L was overexpressed in human HCC tissues compared with peri-tumoral tissues. Downregulation of UBAP2L inhibited migration, invasion and the EMT in highly metastatic HCC cell lines. Furthermore, UBAP2L knockdown inhibited expression of the transcriptional repressor SNAIL1 and its ability to bind to the E-cadherin promoter via SMAD2 signaling pathway, which in turn resulted in increased E-cadherin expression. Additionally, bioinformatics analysis showed that expression of UBAP2L is correlated with poor prognosis in patients with HCC. Conclusions: UBAP2L plays a critical role in maintenance of the metastatic ability of HCC cells via SNAIL1 Regulation and is predictive of a poor clinical outcome.
Downregulation of UBAP2L Inhibits the

Introduction
Hepatocellular carcinoma (HCC) is one of the most prevalent cancers and the third leading cause of cancer-related death [1, 2] . Despite rapid developments in therapeutic management, including early screening, targeted drugs, local therapeutics and hepatectomy, the 5-year survival rate has not improved significantly in nearly half a century. The aggressiveness of HCC is responsible for its rapid progression and low sensitivity to treatment. The epithelialmesenchymal transition (EMT) plays a pivotal role in local invasion and distant metastasis during HCC progression [3] [4] [5] [6] [7] . E-cadherin is a marker of epithelial cells and is critical for maintenance of a polar epithelium [8] . EMT initiation in HCC cells is marked by the loss of E-cadherin expression [9] . Previous studies have reported that a series of transcriptional factors-including SNAIL1, SNAIL2, ZEB1, ZEB2, TWIST and PRRX1-are involved in regulating E-cadherin expression and triggering the EMT [10] [11] [12] [13] [14] [15] [16] . However, the key events that act upstream of these factors in HCC are unclear.
Ubiquitin associated protein 2-like (UBAP2L) is a widely conserved protein with an ubiquitin-associated domain and multiple RGG/RG repeats at the N-terminus. UBAP2L interacts with the polycomb complex protein B lymphoma Moloney murine leukemia virus insertion region 1 (BMI1) to maintain hematopoietic stem cell activity [17] and plays an important role in the progression of mitosis by correcting kinetochore-microtubule attachment [18] . BMI1 is a well-known polycomb group (PcG) protein that has been reported to be associated with the EMT of cancer cells [19] . However, as a component of BMI1-containing protein complexes, whether UBAP2L plays a role in EMT is unclear. Recent studies have demonstrated that UBAP2L expression is increased in myeloma and HCC [20] [21] [22] and involved in the growth and migration of glioma and prostate cancer [23, 24] ; however, the function of UBAP2L in HCC has not been investigated.
In the present study, we found that UBAP2L was highly expressed in the majority of HCC tissues and high-metastatic-potential HCC cell lines. Downregulation of UBAP2L significantly suppressed the migration, invasion and EMT of HCC cells in vitro by inhibiting the expression and binding of SNAIL1 to the E-cadherin promoter.
Materials and Methods
Tissue specimens RNA and protein samples from human HCC and matching peri-tumoral normal tissues were collected from twelve patients who were admitted to Fudan University Shanghai Cancer Center. All patients underwent surgery with no chemotherapy, radiotherapy or any other adjuvant therapy. All samples were subsequently diagnosed as primary HCC by the Department of Pathology.
Ethics statement
Written informed consent was obtained from all subjects, and all protocols were approved by the Institutional Review Board of Fudan University.
Cell lines and cell culture
The HCCLM3, MHCC97H and MHCC97L cell lines were established at the Liver Cancer Institute of Fudan University and authenticated by short-tandem-repeat validation analysis during the study period. HepG2, SMMC-7721, Huh7, Hep3B and normal liver HL-7702 cells were purchased from the Cell Bank of China Academy of Sciences (Shanghai, China) and routinely checked for Mycoplasma contamination by Hoechst staining. Cell lines were cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM; Gibco, USA) supplemented with 10% fetal bovine serum (FBS) (Gibco, USA), 10 µg/ml streptomycin sulfate and 100 µg/ml penicillin G. Cells were incubated at 37 C in a humidified atmosphere containing 5% CO 2 .
RNA isolation and real-time PCR analysis
Total RNA was extracted from fresh tissues and cells using TRIzol reagent (Invitrogen, CA, USA) according to the manufacturer's protocol. Total RNA (500 ng) was reverse-transcribed into complementary DNA using the Reverse Transcription Reagent Kit (TaKaRa, Japan). Real-time PCR analysis was performed using the 7500 Real-Time PCR system (Applied Biosystems, USA) with a SYBR Green PCR Amplification Kit (TaKaRa). Primers are shown in Table 1 . Each PCR analysis was performed in triplicate, and the results were normalized to β actin expression. The 2 -△△Ct method was used for data analysis.
Western blot analysis
Total proteins from fresh tissues and cells were extracted using RIPA Protein Lysis solution (Pierce, IL, USA) and quantified by the Bradford method. Prepared samples were electrophoresed by sodium dodecyl sulfate polyacrylamide gel electrophoresis and blotted onto a polyvinylidene fluoride membrane (Millipore, MA, USA) using the Tetra Handcast system (Bio-Rad, USA). The membranes were blocked for 1 h at room temperature in Tris-buffered saline with 0.05% Tween (TBST) containing 5% non-fat milk and incubated overnight at 4°C with the appropriate primary antibody. After washing in TBST, the membranes were incubated with the secondary antibody and visualized using an electrochemiluminescence kit (Pierce, IL, USA). The protein bands were detected and quantified using the Gene Gnome Syngene Bio Imaging System (Syngene, UK).
The primary anti-UBAP2L antibody was purchased from Abcam (MA, USA), and the anti-β actin antibody was purchased from Santa Cruz Biotechnology Inc. (CA, USA). Other primary antibodies (anti-Ecadherin, anti-CK-18, anti-Claudin7, anti-N-cadherin, anti-vimentin, anti-SNAIL1, anti-STAT3, anti-p-STAT3, anti-P38 MAPK, anti-p-P38 MAPK, anti-SMAD2, anti-p-SMAD2, anti-P65, anti-p-P65, anti-JNK, and anti-p-JNK) were purchased from Cell Signaling Pathway (MA, USA). Anti-mouse or anti-rabbit HRP-conjugated secondary antibodies were used (Santa Cruz Biotechnology Inc.).
Lentivirus construction
Lentivirus construction of UBAP2L-shRNA and mock-shRNA were purchased from Shanghai Genechem Company. The designed shRNA sequences are described in Table 2 . Stable UBAP2L knockdown HCC cell lines were confirmed by quantitative real-time PCR and Western blot analysis.
Cell transfection UBAP2L overexpression and SNAIL1 overexpression were performed by transfected with UBAP2L plasmid and SNAIL1 plasmid (GenePharma, China) using Lipofectamine 2000 (Invitrogen, USA) according Table 1 . Primers for PCR used in this study to the manufacturer's instructions. Triplicate samples were run in all experiments, which were repeated at least three times.
Wound-healing migration assays HCC cells were cultured until monolayer formation and then serum-starved for 12 h. The cell monolayer was wounded using a 10 μl plastic pipette tip. The remaining cells were washed twice with culture medium to remove cell debris and incubated at 37°C in normal serum-containing culture medium with the presence of mitomycin C (10ug/ml) to avoid the influence of cell proliferation. At 0 and 48 h, migrating cells at the wound front were photographed. The percentage of the cleared area at each time point compared with that at time zero was determined using the Image-Pro Plus v. 6.2 software.
Cell migration and invasion assays
Cell migration and invasion assays were performed using 24-well Transwell chambers (8 μm pore size; Millipore) precoated with or without 80 µl Matrigel (1:5 dilution; BD Biosciences, San Jose, CA, USA). Briefly, 1 × 10 5 cells were suspended in 100 μl serum-free medium with the presence of mitomycin C (10ug/ ml), and added to the upper chamber, and 600 μl DMEM supplemented with 20% FBS and 10ug/ml of mitomycin C were placed in the lower chamber. After 24 or 48 h of incubation cells on the surface of the membrane were fixed in 4% paraformaldehyde and stained with 1% crystal violet. The Matrigel and cells remaining in the upper chamber were removed using cotton swabs. Cells in five microscopic fields were counted and photographed (200× magnification). All experiments were performed in triplicate.
Luciferase reporter assays
Luciferase reporter gene constructs containing intact E-cadherin promoter sequences or a E-cadherin promoter sequence with specific mutations in the E-box elements were described in detail previously [25, 26] . UBAP2L-shRNA stable HCC cells were cultured in 24-well plates and transfected with 1 µg reporter gene constructs [E-cadherin (-108)-Luc, E-box-mutated E-cadherin (-108)-AMut-Luc, E-box-mutated E-cadherin (-108)-CMut-Luc, or E-box-mutated E-cadherin (-108)-ABCMut-Luc] using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. After 24 h of transfection, luciferase activities were measured using the Dual-Glo™ Luciferase Assay System kit (Promega). Luciferase intensities were normalized to the activity of Renilla luciferase. Triplicate samples were run in all experiments, which were repeated at least three times.
Chromatin Immunoprecipitation Assay
As described previously [27] , HCC cells were fixed with 1% formaldehyde and processed with the ChIP-IT Enzymatic kit (Active Motif, Carlsbad, CA) following the manufacturer's protocol. The resulting protein/ DNA complexes were then immunoprecipitated overnight at 4℃ using anti-SNAIL1 antibody(Abcam, MA, USA), non-specific IgG antibodies (Santa Cruz Biotechnology Inc., CA, USA), respectively, with protein G magnetic beads. The cross-linked protein/DNA complexes were eluted from G beads at 94°C for 15 minutes and then treated with proteinase K at 37°C for 1 hour to reverse protein/DNA complex. Stop buffer was subsequently added to inhibit proteinase K function. The PCRs were conducted using the primers for E-cadherin promoter (Table 1) .
Survival analysis
Univariate associations between expression profiles and survival were reassessed by Cox regression using the coxph function in the R statistical software package "survival" [28] . Differences between survival curves and log rank P values were reassessed using the survdiff function of the "survival" package. Clinical survival information and normalized RNA-Seq expression data of tumor samples were downloaded from Broad GDAC FIREHOSE on 2014-12-06 (http://gdac.broadinstitute.org/runs/stddata__2014_12_06/). Only 339 cases of HCC had both RNA-Seq expression data and corresponding clinical information available. These data were used to build survival models.
Results
UBAP2L expression is frequently upregulated in human HCCs
The UBAP2L mRNA level in HCC tissues was evaluated by ONCOMINE data-mining analysis. UBAP2L expression was significantly higher in human HCCs compared with normal liver tissue (Fig. 1A) . UBAP2L expression was next analyzed in human HCC tissues and matched peri-tumor tissues by western blot and quantitative real-time (qRT) PCR analyses. UBAP2L mRNA and protein levels were higher in 9/12 HCC tissues than in matched peritumor tissues (Fig. 1B and 1C) . Additionally, we investigated UBAP2L expression in various HCC cell lines. LM3 and 97H cells have greater metastatic potential than that of other HCC cell lines (97L, Hep3B, Huh7 and HepG2) or normal liver L02 cells. UBAP2L expression was significantly higher in the highly metastatic HCC cell lines (Fig. 1D) . These results suggest that UBAP2L expression is frequently upregulated in human HCCs.
Downregulation of UBAP2L inhibits the migration and invasion of HCC cells
To further explore the biological significance of UBAP2L in HCC, we performed shRNAmediated stable UBAP2L knockdown in LM3 and 97H cells, and overexpressed UBAP2L in L-02 cells. The efficacy of UBAP2L down-and up-regulation was confirmed by qRT-PCR and western blot analyses ( Fig. 2A, 2B , and 2D). UBAP2L-knockdown cells exhibited an epitheliallike morphology, rather than the mesenchymal spindle-like morphology characteristic of LM3-mock and 97H-mock cells (Fig. 2C) . While upregulation of UBAP2L in L-02 cells exhibited the opposite phenotype (Fig. 2E) . The results indicated that UBAP2L is necessary for maintenance of the mesenchymal morphology and may affect the EMT. shRNA1 resulted in 80% downregulation of UBAP2L expression, while shRNA2 and shRNA3 resulted in 50% of that. Therefore, shRNA1 was chosen to further studying. We investigated the migration and invasiveness of HCC cells and L-02 cells with the presence of mitomycin C (10ug/ml). In wound-healing migration assays, LM3-shRNA1 and 97H-shRNA1 cells exhibited a significant delay in migration at 48 h post-wounding compared with control cells (Fig. 3A) . Similarly, 
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in transwell invasion assays, the numbers of invasive LM3-mock and 97H-mock cells were significantly higher than those of LM3-shRNA1 and 97H-shRNA1 cells (Fig. 3B) . While upregulation of UBAP2L in L-02 cells exhibited the opposite phenotype ( Fig. 3C and 3D ). These results indicate that downregulation of UBAP2L inhibits HCC cell migration and invasion in vitro. 
UBAP2L regulates EMT and E-cadherin expression in HCC cells
EMT is critical for local invasion and distant metastasis of cancer. To further confirm the role of UBAP2L in the EMT, the expression of EMT-related markers was detected. We found that UBAP2L-knockdown in LM3 and 97H cells upregulated the expression of epithelial markers (E-cadherin, CK-18) and downregulated that of mesenchymal markers (N-cadherin, vimentin, and Claudin7) (Fig. 4A-4C) . Moreover, UBAP2L inhibition resulted in an at least twofold increase in E-cadherin promoter activity (Fig. 4D) .
E-box elements in the E-cadherin promoter play a critical negative regulatory role in E-cadherin gene transcription. To explore the effect of UBAP2L knockdown on E-cadherin activity, we assayed promoter activity using luciferase reporter gene constructs with specific mutations in the E-box elements [E-box-mutated E-cadherin (-108)-AMut-Luc, E-boxmutated E-cadherin (-108)-CMut-Luc, or E-box-mutated E-cadherin (-108)-ABCMut-Luc]. As shown in Figure 4E , UBAP2L-knockdown failed to increase the activity of the E-cadherin promoter with a mutation in the E-box element (Fig. 4E) . Therefore, UBAP2L inhibition enhances E-cadherin promoter activity in a manner dependent on intact proximal E-box elements.
UBAP2L knockdown inhibits the SNAIL1 expression via activating SMAD2 signaling pathway
Several key transcription factors-including SNAIL1, SNAIL2, ZEB1, ZEB2, TWIST and PRRX1-act as transcriptional inhibitors of E-cadherin expression and induce the EMT. We next investigated whether UBAP2L regulates the levels of these transcriptional factors. 5G). To further explore the mechanism underlying UBAP2L-mediated Snail1 expression, we detected the phosphorylation state of STAT3, p38 MAPK, JNK, p65, SMAD2 signaling pathways which were involved in SNAIL1 expression and the EMT. We found that downregulation of UBAP2L inhibited the phosphorylation levels of SMAD2, and up-regulation of UBAP2L in L-02 cells activated the phosphorylation of SMAD2 (Fig. 5K) . The data suggests that UBAP2L regulates the SNAIL1 expression via SMAD2 signaling pathway.
Expression of UBAP2L is correlated with a poor prognosis in patients with HCC
To assess the significance of UBAP2L expression in HCC prognosis, we downloaded HCC gene expression data and clinical information from the TCGA database (https://tcga-data. nci.nih.gov). Only 339 cases of HCC had both RNA-Seq expression data and corresponding clinical information available. These data were used to generate survival models. As shown in Figure 6 , the overall survival rates of UBAP2L high patients with HCC were significantly lower than those of UBAP2L low patients (Fig. 6) , suggesting that UBAP2L expression might be a biomarker of a poor prognosis in patients with HCC.
Discussion
The molecular mechanism by which cancer cells undergo the EMT are unclear. In the present study, we demonstrated that UBAP2L was expressed at higher levels in HCC tissues compared with matched peri-tumoral tissues. Knockdown of UBAP2L significantly inhibited the EMT by downregulating SNAIL1 expression and binding to the E-cadherin promoter. Omics data analysis showed that UBAP2L expression is correlated with a poor prognosis in patients with HCC.
Local invasion and distant metastasis are responsible for the poor prognosis of patients with HCC. The 5-year survival rate of patients with HCC with regional invasion is 7%, and that of those with distant metastasis is 3% [29] . The EMT has been observed in various subsets of cancer cells and is essential for successful migration and seeding [10, 30] . In The loss of epithelial cell junction proteins, such as E-cadherin, and gain of mesenchymal markers, such as vimentin and N-cadherin, are critical for initiating the EMT [31] . We thus determined the effect of UBAP2L knockdown on these markers. The results indicated a marked increase in E-cadherin mRNA and protein levels and a decrease in N-cadherin and vimentin expression. Moreover, E-cadherin promoter activity was significantly increased by high patients with HCC were significantly lower than those of UBAP2L low patients.
UBAP2L knockdown. The E-cadherin promoter contains three E-boxes (A, B, C), a CCAAT box and a GC-rich element [26] . The E-box sequences mediate strong transcriptional repression of E-cadherin expression [32] . E-box C has been reported to play a more important role in repression of E-cadherin gene transcription than has E-box A, while E-box B does not modulate E-cadherin expression [26] . Thus, we generated three mutant reporter gene constructs: E-box A, E-box C and E-box ABC. Luciferase activity was higher in the E-box C mutant and E-box ABC mutant than in the E-box A mutant, in accordance with previous reports. Additionally, UBAP2L knockdown failed to modulate the activity of these mutant reporter genes, suggesting an important role for E-boxes in UBAP2L-mediated E-cadherin expression.
Transcriptional repression by factors such as SNAIL1, SNAIL2, ZEB1, ZEB2, TWIST and PRRX1 is a common mechanism of loss of E-cadherin expression [10] [11] [12] [13] [14] . SNAIL1, SNAIL2, ZEB1 and ZEB2 are zinc-finger transcription factors that bind E-box elements and repress endogenous E-cadherin expression [26, 33, 34] . TWIST, a highly conserved basic helixloop-helix transcription factor, plays a key role in repression of E-cadherin expression [35] . PRRX1, a EMT inducer, enhances the mesenchymal and stem-like phenotype of cancer cells [36] . Upregulation of these transcriptional repressors and downregulation of E-cadherin have been reported in several human cancers. In this study, we found that SNAIL1 mRNA and protein levels were significantly altered by UBAP2L. Moreover, the binding of SNAIL1 to the E-cadherin promoter was inhibited by UBAP2L knockdown. These results suggest that SNAIL1 is critical for UBAP2L-mediated EMT in HCC cells.
SMAD2 pathway is the canonical TGFβ signaling pathway, which is a crucial regulator of EMT and plays critical role in cancer progression [37] . Snail1 expression is also regulated by SMAD2 pathway in previous reports [38, 39] . We showed herein that UBAP2L enhanced the phosphorylation of SMAD2, suggesting a potential role of SMAD2 signaling pathway in UBAP2L-regulated Snail1 expression and EMT. The ligand TGFβ activates receptor serine kinases on the plasma membrane, which phosphorylate SMAD proteins and translocate it to the nucleus. Receptor-mediated signal-transduction pathway leads to multi-ubiquitination and degradation of SMAD2 by the proteasome. If the degradation is averted, phosphorylated SMAD2 would accumulate in the nucleus in active state [40, 41] . UBAP2L is a protein involved in ubiquitin conjugation. We hypothesis that UBAP2L is involved in the process of SMAD2 ubiquitination. However, the concrete function of UBAP2L in ubiquitination is still obscure. Further investigation of the mechanism by which UBAP2L increased SMAD2 phosphorylation would be conducted in our subsequent work.
In conclusion, we have experimentally demonstrated that downregulation of UBAP2L inhibits the migration, invasion and EMT of HCC cells by regulating the binding of SNAIL1 to the E-cadherin promoter. UBAP2L expression is correlated with a poor prognosis of patients with HCC and could thus serve as a novel prognostic indicator.
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